fbpx

Apollo: Trial of the combination of immunotherapy Nivolumab with CBT-101 (an oral c-Met inhibitor) in locally advanced or metastatic renal cell carcinoma who have progressed on previous therapy.  For more information, please click here or phone (08) 9242 7640.

CheckMate-9ER: Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma.  For more information, please click here or phone (08) 9242 7640.